These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 38693730)
21. Probiotics in Inflammatory Bowel Disease. Abraham BP; Quigley EMM Gastroenterol Clin North Am; 2017 Dec; 46(4):769-782. PubMed ID: 29173520 [TBL] [Abstract][Full Text] [Related]
22. Bifidobacterium and Lactobacillus improve inflammatory bowel disease in zebrafish of different ages by regulating the intestinal mucosal barrier and microbiota. Ni Y; Zhang Y; Zheng L; Rong N; Yang Y; Gong P; Yang Y; Siwu X; Zhang C; Zhu L; Fu Z Life Sci; 2023 Jul; 324():121699. PubMed ID: 37061125 [TBL] [Abstract][Full Text] [Related]
23. Probiotics for inflammatory bowel disease: Is there sufficient evidence? Ma Y; Yang D; Huang J; Liu K; Liu H; Wu H; Bao C Open Life Sci; 2024; 19(1):20220821. PubMed ID: 38585636 [TBL] [Abstract][Full Text] [Related]
24. Update on the role of probiotics in the therapy of pediatric inflammatory bowel disease. Guandalini S Expert Rev Clin Immunol; 2010 Jan; 6(1):47-54. PubMed ID: 20383890 [TBL] [Abstract][Full Text] [Related]
25. Probiotics in inflammatory bowel diseases and associated conditions. Mack DR Nutrients; 2011 Feb; 3(2):245-64. PubMed ID: 22254095 [TBL] [Abstract][Full Text] [Related]
26. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies. Magro F; Portela F BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228 [TBL] [Abstract][Full Text] [Related]
28. Probiotics in the Treatment of Inflammatory Bowel Disease. Guandalini S; Sansotta N Adv Exp Med Biol; 2019; 1125():101-107. PubMed ID: 30632114 [TBL] [Abstract][Full Text] [Related]
29. The effects of probiotics, prebiotics and synbiotics on the reduction of IBD complications, a periodic review during 2009-2020. Darb Emamie A; Rajabpour M; Ghanavati R; Asadolahi P; Farzi S; Sobouti B; Darbandi A J Appl Microbiol; 2021 Jun; 130(6):1823-1838. PubMed ID: 33098703 [TBL] [Abstract][Full Text] [Related]
30. Probiotics and antibiotics in IBD. Sokol H Dig Dis; 2014; 32 Suppl 1():10-7. PubMed ID: 25531348 [TBL] [Abstract][Full Text] [Related]
31. A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn's disease. Bjarnason I; Sission G; Hayee B Inflammopharmacology; 2019 Jun; 27(3):465-473. PubMed ID: 31054010 [TBL] [Abstract][Full Text] [Related]
32. The role of the fecal microbiota in inflammatory bowel disease. Khalaf R; Sciberras M; Ellul P Eur J Gastroenterol Hepatol; 2024 Nov; 36(11):1249-1258. PubMed ID: 38973540 [TBL] [Abstract][Full Text] [Related]
33. Gut Microbial Metabolite Butyrate and Its Therapeutic Role in Inflammatory Bowel Disease: A Literature Review. Recharla N; Geesala R; Shi XZ Nutrients; 2023 May; 15(10):. PubMed ID: 37242159 [No Abstract] [Full Text] [Related]
34. Probiotics for induction of remission in Crohn's disease. Limketkai BN; Akobeng AK; Gordon M; Adepoju AA Cochrane Database Syst Rev; 2020 Jul; 7(7):CD006634. PubMed ID: 32678465 [TBL] [Abstract][Full Text] [Related]
35. Nutritional Support and Probiotics as a Potential Treatment of IBD. Tarasiuk A; Eibl G Curr Drug Targets; 2020; 21(14):1417-1427. PubMed ID: 32364071 [TBL] [Abstract][Full Text] [Related]
36. The Role of Genetically Engineered Probiotics for Treatment of Inflammatory Bowel Disease: A Systematic Review. Zhang T; Zhang J; Duan L Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049407 [TBL] [Abstract][Full Text] [Related]
37. The Role of Probiotics in Inducing and Maintaining Remission in Crohn's Disease and Ulcerative Colitis: A Systematic Review of the Literature. Vakadaris G; Stefanis C; Giorgi E; Brouvalis M; Voidarou CC; Kourkoutas Y; Tsigalou C; Bezirtzoglou E Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831029 [TBL] [Abstract][Full Text] [Related]
38. Inflammatory Bowel Disease Therapeutics: A Focus on Probiotic Engineering. Mishra J; Stubbs M; Kuang L; Vara N; Kumar P; Kumar N Mediators Inflamm; 2022; 2022():9621668. PubMed ID: 35082553 [TBL] [Abstract][Full Text] [Related]
39. Probiotics in irritable bowel syndrome and inflammatory bowel disease: review of mechanisms and effectiveness. So D; Quigley EMM; Whelan K Curr Opin Gastroenterol; 2023 Mar; 39(2):103-109. PubMed ID: 36821458 [TBL] [Abstract][Full Text] [Related]